Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad M Kormos

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
ACS Medicinal Chemistry Letters|July 26, 2017
Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor AntagonistsChad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Vaccine|October 21, 2019
Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in ratsSamantha J McClenahan, Chad M Kormos, Melinda Gunnell, et al.
Journal of Medicinal Chemistry|August 19, 2014
Design, synthesis, and biological evaluation of (3R)-1,2,3,4-tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) analogues: in vitro pharmacology and ADME profileChad M Kormos, Moses G Gichinga, Rangan Maitra, et al.
Bioorganic & Medicinal Chemistry|September 7, 2015
Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituentsF Ivy Carroll, Moses G Gichinga, Chad M Kormos, et al.
Journal of Medicinal Chemistry|May 9, 2013
Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonistsChad M Kormos, Chunyang Jin, Juan Pablo Cueva, et al.
Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
ACS Medicinal Chemistry Letters|July 26, 2017
Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor AntagonistsChad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Vaccine|October 21, 2019
Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in ratsSamantha J McClenahan, Chad M Kormos, Melinda Gunnell, et al.
Journal of Medicinal Chemistry|August 19, 2014
Design, synthesis, and biological evaluation of (3R)-1,2,3,4-tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl]-3-isoquinolinecarboxamide (JDTic) analogues: in vitro pharmacology and ADME profileChad M Kormos, Moses G Gichinga, Rangan Maitra, et al.
Bioorganic & Medicinal Chemistry|September 7, 2015
Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituentsF Ivy Carroll, Moses G Gichinga, Chad M Kormos, et al.
Journal of Medicinal Chemistry|May 9, 2013
Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonistsChad M Kormos, Chunyang Jin, Juan Pablo Cueva, et al.
Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Pageof 2